Carregant...
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...
Guardat en:
| Publicat a: | Breast Cancer (Auckl) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Libertas Academica
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214808/ https://ncbi.nlm.nih.gov/pubmed/28096680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S12443 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|